BSX: Boston Scientific Corporation Stock

by  •  • Comments Off on BSX: Boston Scientific Corporation Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 99,100.35
Enterprise Value ($M) 107,580.35
Book Value ($M) 19,129.00
Book Value / Share 13.01
Price / Book 5.18
NCAV ($M) -9,092.00
NCAV / Share -6.19
Price / NCAV -10.90

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.09

Liquidity (mrq)
Quick Ratio 0.82
Current Ratio 1.32

Balance Sheet (mrq) ($M)
Current Assets 6,514.00
Assets 35,136.00
Liabilities 15,606.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 14,240.00
Operating Income 2,547.00
Net Income 1,593.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,503.00
Cash from Investing -2,574.00
Cash from Financing 5.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 8.56 5.62
02-09 13G/A Massachusetts Financial Services Co /ma/ 3.90 -30.67
02-09 13G/A Fmr Llc 9.53 32.63
01-25 13G/A BlackRock Inc. 8.70 -7.81

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-21 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934, or For the fiscal year ended December 31, 2023 ☐ TRANSITION
2024-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934, or For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 866,852 5,703,396 15.20
2024-04-18 863,659 5,112,085 16.89
2024-04-17 802,241 5,277,650 15.20
2024-04-16 951,344 6,619,233 14.37
2024-04-15 682,618 6,527,104 10.46

(click for more detail)

Similar Companies
BDX – Becton, Dickinson and Company BFLY – Butterfly Network, Inc.
BLUA.U – BlueRiver Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-third of a CDRE – Cadre Holdings, Inc.
CNMD – CONMED Corporation


Financial data and stock pages provided by
Fintel.io

Finpedia: Boston Scientific Corporation